Paras Healthcare shares: After IPO listing gains, check what's happening with stock - Buy, sell or hold?Experts weigh in

Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹900 target, citing growth in specialised care and operational improvements.
Read the full story on Mint Opens livemint.com in a new tab
Advertisement
OZYNIXCRM, HRMS & Business ToolsAI-powered business software — early access openContact us
This is a short summary of a story published by Mint, shown with a link to the original. The full story, photo and reporting belong to Mint.











